NBPF8 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the NBPF8 protein, a member of the neuroblastoma breakpoint family (NBPF). The NBPF family is a group of proteins primarily associated with human evolution and neurodevelopment. NBPF8, like other NBPF members, is thought to play a significant role in cell division, genomic stability, and regulation of protein expression. Inhibitors of NBPF8 interfere with its normal cellular functions, potentially by binding to key regions of the protein and preventing it from interacting with other molecules necessary for its activity. These inhibitors can act through various mechanisms, including direct binding to the active site of NBPF8 or altering its structure to impact its function.
The study of NBPF8 inhibitors is crucial for gaining deeper insights into the biological significance of NBPF8 and its role in cellular processes. By inhibiting the function of NBPF8, researchers can better understand its contributions to cell signaling, proliferation, and other pathways essential for maintaining proper cellular behavior. These inhibitors serve as important tools for dissecting the molecular pathways in which NBPF8 is involved, allowing for a clearer picture of how it contributes to normal and abnormal cellular functions. Additionally, NBPF8 inhibitors help researchers explore the evolutionary implications of the NBPF family, particularly in relation to human-specific developmental traits. Through continued research, the role of NBPF8 in broader biological systems can be elucidated, enhancing our knowledge of cell biology and protein regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting RNA polymerase and thus potentially decreasing gene expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin is a potent inhibitor of RNA polymerase II, which could reduce mRNA synthesis of genes like NBPF8. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide is known to inhibit transcriptional activity by affecting RNA polymerase II, which could downregulate gene expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB is an adenosine analog that inhibits RNA polymerase II transcription elongation, potentially lowering gene expression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol inhibits cyclin-dependent kinases, which are necessary for RNA polymerase II-mediated transcription. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor that displaces BET proteins from chromatin, affecting the expression of genes. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor that can lead to demethylation of genes and potentially alter their expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, inhibiting transcription factors from binding and thus can decrease gene expression. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a competitive inhibitor of p300/CBP histone acetyltransferases, which can alter gene expression patterns. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $271.00 $5202.00 $40368.00 $704.00 | 4 | |
Sinefungin is an inhibitor of S-adenosylmethionine-dependent methyltransferases, which could affect methylation status of genes and their expression. | ||||||